Jetzt publik gewordene Lobbyschreiben und andere Dokumente legen nahe, dass die Pharmaindustrie die Bundesregierung bei Impfstoffpatenten auf Kurs brachte.
03.09.2022
Von Stefan Krempl
Vernunft im 21. Jahrhundert
Startseite » Medienspiegel » Impfstoffe: Wie Biontech & Co. die Regierung von einer Patentfreigabe abbrachten
Jetzt publik gewordene Lobbyschreiben und andere Dokumente legen nahe, dass die Pharmaindustrie die Bundesregierung bei Impfstoffpatenten auf Kurs brachte.
03.09.2022
Von Stefan Krempl
Cookie | Dauer | Beschreibung |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |